Patients diagnosed with pediatric renal and rhabdoid tumors are faced with great challenges. From the burden of side effects induced by the current heavy therapy regimens, to the inadequate treatment options available for high-risk patients. The need for improved therapeutic is therefore urgent. During my PhD project, I focus on using patient-derived organoids established in our lab as drug screening platform to identify novel tumor-specific therapeutic vulnerabilities. In my free time I enjoy singing in a choir and cooking new recipes.